Peer Review History: Are Patients on Cyclophosphamide at Higher Risk of Covid-19 Complications?

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.9/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Lovely Gupta, India) | File 1 | File 2

Stage 2 | Peer review report_2 (Ashraf Mohamed Barakat, Egypt) | File 1 | File 2

Stage 2 | Peer review report_3 (Zahra Kiani, Iran) | File 1 | NA

Stage 2 | Peer review report_4 (Yazi Abdullah Jassim, Iraq) | File 1 | File 2

Stage 2 | Peer review report_5 (Ali Adel Dawood, Iraq) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Comment_Editor_2_v1 | File 1 | NA

Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | File 2

Stage 3 | Comment_Editor_3_v1 | File 1 | NA